
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67276
Internal Medicine
Rheumatology
Ophthalmology
Insight Into Systemic Lupus Erythematosus: Unveiling Central Retinal Artery Occlusion as an Initial Indicator
Muacevic Alexander
Adler John R
Khan Malik Hasnat ul Hassan 1
Sarfaraz Haider 1
Khan Nida 1
Mushtaq Muhammad Hamza 1
Aftab Ahmad Syed 2
Abbas Muhammad 1
Habib Ihtisham 1
Amin Noor Muhammad 1
1 Internal Medicine, Medical Teaching Institute, Lady Reading Hospital Peshawar, Peshawar, PAK
2 Internal Medicine, Medical Teaching Institute, Khyber Teaching Hospital Peshawar, Peshawar, PAK
Malik Hasnat ul Hassan Khan ihasnat03@gmail.com
20 8 2024
8 2024
16 8 e6727619 8 2024
Copyright © 2024, Khan et al.
2024
Khan et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/277571-insight-into-systemic-lupus-erythematosus-unveiling-central-retinal-artery-occlusion-as-an-initial-indicator
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder with diverse clinical manifestations. Among these, ocular complications are notably prevalent, affecting up to one-third of patients. One rare but serious ocular complication of SLE is central retinal artery occlusion (CRAO), which can result in significant vision loss. We report a case of a young woman with sudden, painless vision loss in her right eye over two days. Fundoscopy confirmed CRAO, with no light perception in the affected eye and normal vision in the left eye. Physical examination revealed symptoms suggestive of a connective tissue disorder, including malar rash and Raynaud’s phenomenon. Laboratory tests confirmed SLE. Despite treatment with methylprednisolone, hydroxychloroquine, aspirin, and nifedipine, the patient’s vision did not improve. CRAO in SLE indicates severe retinal vasculopathy and has a poor prognosis. This case highlights the importance of considering SLE in patients with sudden vision loss and systemic symptoms, emphasizing early diagnosis and comprehensive management to prevent severe complications.

connective tissue disorder
systemic lupus erythematosis
micro-vasculopathy
central retinal artery occlusion (crao)
sudden vision loss
==== Body
pmcIntroduction

Systemic lupus erythematosus (SLE) is a multisystem chronic autoimmune disease with a relapsing and remitting course. The disease has varied presentations, ranging from mild mucocutaneous manifestation to multiorgan disease involvement [1]. The exact cause is unknown, but genetic, immunological, endocrine, and environmental factors are believed to trigger the body’s immune response, resulting in excessive pathogenic autoantibodies producing tissue and organ damage [2]. Women are ten times more at risk of developing SLE than men, with a female and male ratio of 9 to 1 [1]. SLE diagnosis is based on laboratory and clinical findings [3]. The treatment depends on the disease's severity and the organs involved [4]. Ocular complications are found in up to one-third of patients with SLE and can range from mild eye irritation to vision-threatening retinopathy [5,6]. Lupus retinopathy is the most vision-threatening ocular manifestation ranging from 3 to 29% of patients affected due to vasculitis of retinal arterioles and capillaries. The occlusion of vessels can result in retinal hemorrhage, exudate, and cotton wool spots. Occlusion of large arteries can result in life-threatening vision loss. Such cases are less prevalent with available treatment modalities [7].

Case presentation

A young married female presented to our hospital outpatient clinic with chief complaints of loss of vision in her right eye. Vision loss was sudden in onset, non-progressive, and non-painful. The episode of vision loss occurred two days prior. Any head or eye pain did not accompany the vision loss. She had no significant past ophthalmologic history and no family history of coagulopathy.

The ophthalmologic examination showed that the right pupil was mid-dilated and non-reactive to light, but responded to an indirect light reflex. There was no ocular redness, discharge, or periorbital swelling. On visual acuity testing, her vision showed no perception of light (NPL) in the right eye and 20/20 in the left eye. Fundoscopy showed central retinal artery occlusion (CRAO) with a pale optic disk and cherry red spot (Figure 1).

Figure 1 Fundus photograph showing cherry red macula (black arrow) and pale optic disc (green arrow).

A detailed physical examination of the patient revealed malar rash, alopecia, polyarthralgia, and Raynaud phenomena. The mentioned physical examination finding raised suspicion of underlying connective tissue disorder, and the patient was admitted to the hospital floor for further workup.

Blood tests were mostly normal, except for a hemoglobin level of 9.89 g/dL and an elevated creatinine level of 1.4 mg/dL (Table 1). Brain MRI, carotid Doppler, and echocardiogram were unremarkable. However, Doppler ultrasonography of the peripheral limbs revealed atherosclerotic changes. Urinalysis showed 1+ protein and 8-10 pus cells and 24-hour urinary protein was 423 mg/24 h (Tables 2, 3). The antinuclear antibody (ANA) screen was positive, and further testing revealed elevated anti-dsDNA antibodies, confirming the diagnosis of SLE. Consultation with the ophthalmology and rheumatology teams led to the initiation of treatment with intravenous methylprednisolone 500 mg daily for three days, along with oral hydroxychloroquine (HCQ), aspirin, and nifedipine. The antiphospholipid antibody screen was negative, and the patient's history did not reveal any miscarriages. Despite maximal pharmacotherapy, the patient showed little to no improvement in right-eye vision. She was discharged on tablet HCQ, tablet aspirin, and sunblock for her face. After a three-month follow-up, the patient reported marked improvement in fatigue and joint pain, but her right eye vision was still NPL.

Table 1 Basic lab investigations.

ALT: alanine transaminase; ESR: erythrocyte sedimentation rate; HCV: hepatitis C virus; HBsAg: hepatitis B surface antigen.

Parameter	Value	Reference range	
Total leukocyte count	7930/ul	4000-11000/ul	
Hemoglobin	9.89 g/dl	11.5-17.5 g/dl	
Platelets	117000/ul	150000-450000/ul	
Hematocrit	83.6 fl	76-96 fl	
HbsAg (by ICT)	Negative	Negative	
Anti-HCV (by ICT)	Negative	Negative	
Serum creatinine	1.41 mg /dl	0.3-0.9 mg/dl	
ALT	20 U/L	10-50 U/L	
ESR	80 mm /first hour	0-20 mm /first hour	

Table 2 Routine urine exam.

RBC: red blood cells; WBC: white blood cells, R.E.: routine examination, HPF: high-powered field. 

Urine R.E	Value	Reference range	
Color	Yellow	Yellow	
Appearance	Clear	Clear	
Glucose	Nil	Negative	
Protein	Positive (+)	Negative	
PUS/WBC	8-10	0-5/HPF	
RBC	1-2	0-5/HPF	
Epithelial cells	Positive (+)	0-10/HPF	
Hyaline cast	Positive (+)	0-4/HPF	
Granular cast	Positive (+)	0/HPF	
Amorphous urates	Nil	Nil	

Table 3 24 hour urinary protein.

Protein-24 hours urine	Value	Reference range	
Volume	800 ml	1500-2000 ml	
24 hours urinary protein	438 mg/24 hours	<150 mg/24 hours	

Discussion

In SLE, thrombotic and inflammatory phenomena can affect the eye. They can cause a range of ocular manifestations, like dry eyes, scleritis, uveitis, ischemic optic neuropathy, and occlusion of retinal vessels. Central retinal artery occlusion (CRAO) presenting in SLE is very uncommon.

There are three types of direct retinal damage in lupus, i.e., microangiopathy, vaso-occlusion, and vasculitis. The major pathology of lupus retinopathy is attributed to vasculopathy, most commonly microangiopathy [8]. The most severe form of life-threatening vision loss is vaso-occlusion, ischemia from blockage of the central retinal artery, as was the case with our patient. Vaso-occlusive retinopathy has a poor prognosis and visual losses are reported in 80% of cases [9]. Posterior segment involvement of the retina can precede systemic features of SLE and may aid in diagnosing and promptly treating patients with SLE, but it is very uncommon [10]. There is also a strong association between this type of lupus retinopathy and antiphospholipid syndrome [11]. Antibodies for antiphospholipid syndrome were negative in our patients; however, they are found in only approximately 30% of SLE patients [12].

Our patient had signs and symptoms suggestive of SLE, namely, polyarthritis, alopecia, malar rash, and Raynaud phenomena, but since she was never diagnosed and had never taken treatment for SLE, sudden vision loss prompted a visit to an ophthalmologist. Physical exam findings raised a suspicion of underlying connective tissue disorder, and the patient was referred to a rheumatologist. She was started on methylprednisone pulse therapy, 500 mg once a day for three days, antiplatelet, hydroxychloroquine, and vasodilators, but she showed little to no improvement in her visual acuity. As mentioned before, vaso-occlusive retinopathy has a poor prognosis. In one case report by Radosavljević et al., a female patient with SLE and associated retinopathy failed to improve even after aggressive steroids and immunosuppressants, and on a four-year follow-up, the disease progressed to retinal neovascularization [13]. 

Treatment of SLE involves multiple drugs like anti-malarial, steroids, immunosuppressants, biologics, and IV immunoglobulins. Still, no consensus exists on treating retinal vaso-occlusive disease in SLE. Antiplatelets and anti-lipids are usually recommended, but the role of steroids and immunosuppressants in retinal vaso-occlusive disease is unclear, and studies have suggested no such particular role in the management [14,15].

The occurrence of CRAO in SLE patients is rare nowadays because of available treatment, but since our patient had never been diagnosed with SLE and only sudden onset vision loss prompted her emergency visit that ultimately led to the diagnosis of SLE.

Conclusions

This case highlights the critical need for early recognition and comprehensive management of systemic lupus erythematosus (SLE), particularly in patients presenting with sudden vision loss and systemic symptoms. Central retinal artery occlusion (CRAO) in SLE is a rare but severe manifestation indicative of underlying vasculopathy and often carries a poor prognosis despite aggressive treatment. The absence of prior SLE diagnosis in our patient underscores the importance of considering SLE in differential diagnoses for acute vision loss. Prompt diagnosis and appropriate multidisciplinary management are essential to mitigate severe complications and improve patient outcomes in SLE.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Malik Hasnat ul Hassan Khan, Haider Sarfaraz, Syed Aftab Ahmad, Nida Khan, Muhammad Abbas, Muhammad Hamza Mushtaq, Ihtisham Habib, Muhammad Amin Noor

Drafting of the manuscript:  Malik Hasnat ul Hassan Khan, Haider Sarfaraz, Syed Aftab Ahmad, Nida Khan, Muhammad Abbas, Muhammad Hamza Mushtaq, Ihtisham Habib, Muhammad Amin Noor

Supervision:  Malik Hasnat ul Hassan Khan, Muhammad Hamza Mushtaq

Critical review of the manuscript for important intellectual content:  Haider Sarfaraz, Syed Aftab Ahmad, Nida Khan, Muhammad Abbas, Muhammad Hamza Mushtaq, Ihtisham Habib, Muhammad Amin Noor
==== Refs
References

1 Systemic lupus erythematosus StatPearls (Internet) Justiz Vaillant AA Goyal A Varacallo M Treasure Island, FL StatPearls Publishing 2023 http://www.ncbi.nlm.nih.gov/books/NBK535405/
2 Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us Arthritis Rheumatol Karrar S Cunninghame Graham DS 496 507 70 2018 29207444
3 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus Arthritis Rheumatol Aringer M Costenbader K Daikh D 1400 1412 71 2019 31385462
4 An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management Cureus Ameer MA Chaudhry H Mushtaq J 0 14 2022
5 Systemic lupus erythematosus (SLE)-EyeWiki 11 2023 2023 https://eyewiki.org/Systemic_Lupus_Erythematosus_(SLE)
6 Bilateral central retinal artery occlusion-a catastrophic presentation of systemic lupus erythematosus Oman J Ophthalmol Ish S Sharma D Verma R Kumari S Garkoti H 149 151 13 2020 33542604
7 Systemic lupus erythematosus and ocular involvement: an overview Clin Exp Med Dammacco R 135 149 18 2018 29243035
8 Ocular manifestations in systemic lupus erythematosus Br J Ophthalmol Silpa-archa S Lee JJ Foster CS 135 141 100 2016 25904124
9 Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment Clin Exp Ophthalmol Au A O'Day J 87 100 32 2004 14746601
10 Systemic lupus erythematosus presenting earlier as retinal vaso-occlusion Korean J Intern Med Song YH Kim CG Kim SD Kim YY Choe JY 210 213 16 2001 11769581
11 Occlusive retinal vascular disease in systemic lupus erythematosus J Rheumatol Hall S Buettner H Luthra HS 846 850 11 1984 https://pubmed.ncbi.nlm.nih.gov/6084063/ 6084063
12 Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance Ann Intern Med Love PE Santoro SA 682 698 112 1990 https://pubmed.ncbi.nlm.nih.gov/2110431/ 2110431
13 Severe vaso-occlusive retinopathy associated with systemic lupus erythematosus Vojnosanit Pregl Radosavljević A Karadžić J Kovačević I Ljikar J Devečerski G 1164 1167 73 2016 https://pubmed.ncbi.nlm.nih.gov/29341575/ 29341575
14 Severe retinal vascular lesions in systemic lupus erythematosus Ann Ophthalmol Kayazawa F Honda A 1291 1294 13 1981 https://pubmed.ncbi.nlm.nih.gov/6173007/ 6173007
15 SLE retinopathy: evaluation by fluorescein angiography Ann Rheum Dis Lanham JG Barrie T Kohner EM Hughes GR 473 478 41 1982 7125716
